Franklin Genomic Advancements ETF Rating $33.63 -0.10 (-0.30%) As of 05/8/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.79Holdings in HELX have an aggregate rating of Moderate Buy based on 384 analyst ratings issued in the past year covering 21 companies (66.0% of the portfolio).HELX Aggregate Price Target$33.63High Prediction$33.63Average Prediction$33.63Low Prediction$33.63Holdings in HELX have an aggregate price target of $33.63 and a range of $33.63 to $33.63 covering 21 companies (66.0% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 HELX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.71%NTRANatera$194.24-11.6%4.3768 of 5 stars2.79$256.00 31.8%19Trending NewsAnalyst ForecastInsider TradeGap DownHigh Trading Volume6.40%GHGuardant Health$95.70+3.7%3.9948 of 5 stars2.86$129.16 35.0%21Trending NewsAnalyst ForecastGap Up5.72%KRYSKrystal Biotech$305.71+3.0%3.251 of 5 stars2.83$324.11 6.0%12News CoverageEarnings ReportAnalyst ForecastAnalyst Revision4.38%UTHRUnited Therapeutics$564.94-0.7%3.2892 of 5 stars2.85$619.42 9.6%13Trending NewsEarnings ReportAnalyst ForecastInsider Trade4.01%LGNDLigand Pharmaceuticals$221.41+5.3%4.2061 of 5 stars2.88$257.71 16.4%8Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.82%BBIOBridgeBio Pharma$67.39-0.1%3.3395 of 5 stars2.92$87.71 30.2%25Trending NewsEarnings Report3.77%INSMInsmed$101.17-3.6%3.2912 of 5 stars3.00$211.86 109.4%25Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume3.03%ADPTAdaptive Biotechnologies$13.81-6.0%3.2606 of 5 stars2.63$20.00 44.8%8Earnings ReportAnalyst Forecast2.77%VRTXVertex Pharmaceuticals$429.82+1.1%4.3814 of 5 stars2.85$555.17 29.2%26Earnings ReportAnalyst ForecastInsider TradeAnalyst Revision2.67%LLYEli Lilly and Company$948.01-2.8%4.9077 of 5 stars2.87$1,218.33 28.5%30Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision2.64%CTVACorteva$81.10+2.6%3.5732 of 5 stars2.59$87.05 7.3%22Trending NewsEarnings ReportAnalyst Forecast2.39%REGNRegeneron Pharmaceuticals$714.89+0.8%4.3338 of 5 stars2.77$826.59 15.6%262.31%ALNYAlnylam Pharmaceuticals$295.05-0.3%4.3031 of 5 stars2.81$471.96 60.0%26Trending NewsAnalyst ForecastAnalyst Revision2.19%TVTXTravere Therapeutics$42.60-0.1%2.053 of 5 stars2.69$47.83 12.3%13Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision2.15%TEMTempus AI$49.86+0.8%3.4316 of 5 stars2.50$70.86 42.1%14Trending NewsEarnings ReportAnalyst Forecast2.06%MEDPMedpace$424.00-1.1%2.781 of 5 stars2.20$467.08 10.2%15Trending News2.04%IONSIonis Pharmaceuticals$75.71-0.4%3.7396 of 5 stars2.86$99.35 31.2%21Analyst Revision1.89%BNTXBioNTech$94.13+1.2%3.513 of 5 stars2.72$131.60 39.8%18News CoverageEarnings ReportAnalyst ForecastBuyback Announcement1.85%TWSTTwist Bioscience$56.85-2.9%1.2989 of 5 stars2.75$56.57 -0.5%8News CoverageEarnings ReportAnalyst Upgrade1.66%NBIXNeurocrine Biosciences$152.25+1.8%2.7951 of 5 stars2.82$184.15 21.0%22Trending NewsAnalyst Forecast1.58%STOKStoke Therapeutics$32.89+0.3%2.7624 of 5 stars2.92$41.83 27.2%12News CoverageEarnings Report This page (BATS:HELX) was last updated on 5/9/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first t...Paradigm Press | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
